References
- Jefferson F. W. A review of the cardiovascular effects and toxicity of tricyclic antidepressants. Psychosom. Med. 1975; 37: 160–179
- Callaham M. Tricyclic antidepressant overdose. JACEP 1979; 8: 413–425
- Williams R. B., Jr., Sherter C. Cardiac complications of tricyclic antidepressant therapy. Ann. Intern. Med. 1971; 74: 395–398
- Kantor S., Bigger T., Glassman A. Imipramine‐induced heart block. J. Am. Med. Assoc. 1975; 231: 1364–1366
- Freeman J. W., Mundy G. R., Beattie R. R., Ryan C. Cardiac abnormalities in poisoning with tricyclic antidepressants. Br. Med. J. 1969; 2: 610–611
- Sigg E., Osborn M., Korol M. Cardiovascular effects of imipramine. J. Pharmacol. 1963; 141: 237–243
- Raisfield J. H. Cardiovascular complications of antidepressant therapy. Interaction at the adrenergic neuron. Am. Heart J. 1972; 83: 129–133
- Rawlings D., Fozzard H. A. Electrophysiologic effects of imipramine on cardiac Purkinje fibers (Abstract). Am. J. Cardiol. 1978; 41: 387
- Weld F. M., Bigger J. T., Jr. Electrophysiological effects of imipramine on ovine cardiac Purkinje and ventricular muscle fibers. Circ. Res. 1980; 46: 167–175
- Slovis T., Ott J., Teitelbaum P., Lipscomb W. Physostigmine therapy in acute tricyclic antidepressant poisoning. Clin. Toxicol. 1971; 4: 451–459
- Heiser J. F., Wilbert D. E. Reversal of delirium induced by tricyclic antidepressant drugs with physostigmine. Am. J. Psychiatry 1974; 131: 1275–1277
- Schärer K. Toxizitätsstudien mit Amitriptyline. Schweiz. Med. Wochenschr. 1965; 95: 173–176
- Nymark N., Rasmussen J. Effects of certain drugs upon amitriptyline induced electrocardiographic changes. Acta Pharmacol. Toxicol. 1966; 24: 148–156
- Tobis J., Das B. N. Cardiac complications in amitriptyline poisoning. Successful treatment with physostigmine. J. Am. Med. Assoc. 1976; 235: 1474–1476
- Bigger J., Kantor S., Glassman A., Perel J. M. Is physostigmine effective for cardiac toxicity of tricyclic antidepressant drugs? (Letter). J. Am. Med. Assoc. 1977; 237: 1311
- Newton R. W. Physostigmine salicylate in the treatment of tricyclic antidepressant overdosage. J. Am. Med. Assoc. 1975; 231: 941–943
- Elonen E. Effects of B‐adrenoreceptor drugs, physostigmine, and atropine on the toxicity of doxepin in mice. Med. Biol. 1975; 53: 231–237
- Brown T. Tricyclic antidepressant overdosage: Experimental studies on the management of circulatory complications. Clin. Toxicol. 1976; 9: 255–272
- Moe G. K., Abildskov J. A. Antiarrhythmic drugs. The Pharmacologic Basis of Therapeutics5th ed., L. S. Goodman, A. Gilman. MacMillan, New York 1975; 688
- Koch‐Weser J. Disopyramide. N. Engl. J. Med. 1979; 300: 957–962
- Giardina E. ‐G.V., Bigger J. T., Jr., Glassman A. H., Perel J. M., Kantor S. J. The electrocardiographic and antiar‐rhythmic effects of imipramine hydrochloride at therapeutic plasma concentrations. Circulation 1979; 60: 1045–1052
- Byck R. Drugs and the treatment of psychiatric disorders. The Pharmacologic Basis of Therapeutics5th ed., L. S. Goodman, A. Gilman. MacMillan, New York 1975; 162
- Avita M., Surawicz B. Electrophysiologic effects of phenothiazines in canine cardiac fibers. J. Pharmacol. Exp. Ther. 1973; 184: 619–630